Prior Herpes Simplex Virus Infection and the Risk of Herpes Zoster
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad259 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Ruth Harbecke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs San Diego Healthcare System, San Diego, California, USA. Hauptthemen laut MEDLINE: Herpes Simplex, Herpes Zoster, Herpesvirus 1, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
The incidence of herpes zoster (HZ) has increased in the United States concurrent with decrease in herpes simplex virus (HSV) prevalence. We hypothesized that lack of HSV-elicited cross-reactive immunity to varicella-zoster virus (VZV) results in an increased risk of HZ. Using specimens from the placebo arm of the Shingles Prevention Study, we investigated whether persons who develop HZ are less likely to have prior HSV infection than persons who do not develop HZ, and whether HZ is less severe in persons with HSV than in HSV seronegative persons.
Methods
We conducted a nested case-control (1:2) study comparing the seroprevalence of HSV-1 and HSV-2 in cases (persons with polymerase chain reaction-confirmed HZ) to age-, sex-, and health-matched controls (persons without HZ).
Results
Sera from 639 study participants (213 cases and 426 controls) yielded definitive HSV antibody results and were analyzed. Overall, HSV seropositivity rate was 75%. HSV seronegativity was significantly higher in HZ cases than controls (30.5% vs 22.3%; P = .024), with a 55% higher risk of HZ in HSV seronegative than HSV seropositive participants. HSV seropositivity was associated with more severe HZ (P = .021).
Conclusions
Our study demonstrated that prior infection with HSV partly protects against HZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterans Affairs San Diego Healthcare System, San Diego, California, USA.
- Department of Medicine, University of California San Diego, San Diego, California, USA.
- Department of Pathology, University of California San Diego, San Diego, California, USA.
- Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
- Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Harbecke, R., Oxman, M. N., Selke, S., Ashbaugh, M. E., Lan, K. F., Koelle, D. M., & Wald, A. (2024). Prior Herpes Simplex Virus Infection and the Risk of Herpes Zoster. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad259
Vancouver
Harbecke R, Oxman MN, Selke S, Ashbaugh ME, Lan KF, Koelle DM, et al. Prior Herpes Simplex Virus Infection and the Risk of Herpes Zoster. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad259
BibTeX
@article{Harbecke2024,
author = {Harbecke, Ruth and Oxman, Michael N and Selke, Stacy and Ashbaugh, Mark E and Lan, Kristine F and Koelle, David M and Wald, Anna},
title = {Prior Herpes Simplex Virus Infection and the Risk of Herpes Zoster},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad259}
}
EUVIMED